{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:34:58Z","timestamp":1789824898279,"version":"4.0.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":411,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.antiviral.2012.03.011","type":"journal-article","created":{"date-parts":[[2012,4,10]],"date-time":"2012-04-10T02:22:46Z","timestamp":1334024566000},"page":"195-207","source":"Crossref","is-referenced-by-count":33,"title":["Inhibition of adenovirus multiplication by short interfering RNAs directly or indirectly targeting the viral DNA replication machinery"],"prefix":"10.1016","volume":"94","author":[{"given":"Doris","family":"Kneidinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirza","family":"Ibri\u0161imovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2012.03.011_b0005","doi-asserted-by":"crossref","first-page":"9556","DOI":"10.1128\/JVI.79.15.9556-9565.2005","article-title":"Suppression of RNA interference by adenovirus virus-associated RNA","volume":"79","author":"Andersson","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1358\/dnp.2010.23.6.1437713","article-title":"Harnessing RNA interference for the treatment of viral infections","volume":"23","author":"Arbuthnot","year":"2010","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.antiviral.2012.03.011_b0015","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1038\/sj.onc.1209040","article-title":"Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus","volume":"24","author":"Berk","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2012.03.011_b0020","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1128\/JVI.02417-08","article-title":"Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation","volume":"83","author":"Blackford","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0025","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0002-9343(99)80169-7","article-title":"Evolving pathogens in allogeneic bone marrow transplantation: increased fatal adenoviral infections","volume":"99","author":"Blanke","year":"1995","journal-title":"Am. J. Med."},{"key":"10.1016\/j.antiviral.2012.03.011_b0030","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","article-title":"Origins and mechanisms of miRNAs and siRNAs","volume":"136","author":"Carthew","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2012.03.011_b0035","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1093\/nar\/gkm543","article-title":"Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC","volume":"35","author":"Castanotto","year":"2007","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.antiviral.2012.03.011_b0040","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2002-02-0377","article-title":"Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery","volume":"100","author":"Chakrabarti","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2012.03.011_b0045","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1631\/jzus.2005.B0236","article-title":"Combination of small interfering RNAs mediates greater inhibition of human hepatitis B virus replication and antigen expression","volume":"6","author":"Chen","year":"2005","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.antiviral.2012.03.011_b0050","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00705-007-0951-z","article-title":"Silencing E1A mRNA by RNA interference inhibits adenovirus replication","volume":"152","author":"Chung","year":"2007","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0055","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1128\/JVI.76.9.4547-4558.2002","article-title":"Bak and Bax function to limit adenovirus replication through apoptosis induction","volume":"76","author":"Cuconati","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrg2968","article-title":"Current prospects for RNA interference-based therapies","volume":"12","author":"Davidson","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.antiviral.2012.03.011_b0065","first-page":"187","article-title":"Adenovirus DNA replication: protein priming, jumping back and the role of the DNA binding protein DBP","volume":"272","author":"de Jong","year":"2003","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0070","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1128\/JCM.00048-06","article-title":"Typing of human adenoviruses in specimens from immunosuppressed patients by PCR-fragment length analysis and real-time quantitative PCR","volume":"44","author":"Ebner","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0075","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/CMR.00052-07","article-title":"Adenoviruses in immunocompromised hosts","volume":"21","author":"Echavarria","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2012.03.011_b0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.antiviral.2010.08.002","article-title":"Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions","volume":"88","author":"Eckstein","year":"2010","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.antiviral.2012.03.011_b0085","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.03.011_b0090","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/sj.gt.3302051","article-title":"A novel tetracycline-controlled transactivator\u2013transrepressor system enables external control of oncolytic adenovirus replication","volume":"10","author":"Fechner","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.antiviral.2012.03.011_b0095","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.03.011_b0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0065-3527(08)60264-X","article-title":"Regulation of adenovirus mRNA formation","volume":"31","author":"Flint","year":"1986","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2012.03.011_b0105","first-page":"287","article-title":"Regulation of mRNA production by the adenoviral E1B 55-kDa and E4 Orf6 proteins","volume":"272","author":"Flint","year":"2003","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0110","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/oli.2006.16.387","article-title":"Combination of active and inactive siRNA targeting the mitotic kinesin Eg5 impairs silencing efficiency in several cancer cell lines","volume":"16","author":"Formstecher","year":"2006","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.antiviral.2012.03.011_b0115","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nrg2504","article-title":"Small silencing RNAs: an expanding universe","volume":"10","author":"Ghildiyal","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.antiviral.2012.03.011_b0330","series-title":"Ocular Infection and Immunity","first-page":"877","article-title":"Adenovirus keratoconjunctivitis","author":"Gordon","year":"1996"},{"key":"10.1016\/j.antiviral.2012.03.011_b0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1977","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0130","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/j.1460-2075.1996.tb00525.x","article-title":"The role of the adenovirus protease on virus entry into cells","volume":"15","author":"Greber","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2012.03.011_b0135","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/nbt1369","article-title":"RNA interference against viruses: strike and counterstrike","volume":"25","author":"Haasnoot","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bmt.1701563","article-title":"Adenovirus infection after pediatric bone marrow transplantation","volume":"23","author":"Hale","year":"1999","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.antiviral.2012.03.011_b0145","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1086\/426831","article-title":"Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro","volume":"191","author":"Hartline","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.03.011_b0150","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1086\/427513","article-title":"Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients","volume":"191","author":"Heemskerk","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.03.011_b0155","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0042-6822(90)90134-D","article-title":"Adenovirus E1A under the control of heterologous promoters: wide variation in E1A expression levels has little effect on virus replication","volume":"179","author":"Hitt","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.03.011_b0160","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1086\/313514","article-title":"Adenovirus infections in hematopoietic stem cell transplant recipients","volume":"29","author":"Howard","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.03.011_b0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrg2936","article-title":"Gene silencing by microRNAs: contributions of translational repression and mRNA decay","volume":"12","author":"Huntzinger","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.antiviral.2012.03.011_b0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrm2321","article-title":"Argonaute proteins: key players in RNA silencing","volume":"9","author":"Hutvagner","year":"2008","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0175","doi-asserted-by":"crossref","first-page":"17831","DOI":"10.1073\/pnas.0407786101","article-title":"Viral DNA synthesis-dependent titration of a cellular repressor activates transcription of the human adenovirus type 2 IVa2 gene","volume":"101","author":"Iftode","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2012.03.011_b0180","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/505498","article-title":"Adenovirus infections in transplant recipients","volume":"43","author":"Ison","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.03.011_b0185","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.tibs.2010.03.009","article-title":"Making RISC","volume":"35","author":"Kawamata","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.antiviral.2012.03.011_b0190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/rmv.386","article-title":"The impact of adenovirus infection on the immunocompromised host","volume":"13","author":"Kojaoghlanian","year":"2003","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0195","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1093\/nar\/gkl589","article-title":"Competition for RISC binding predicts in vitro potency of siRNA","volume":"34","author":"Koller","year":"2006","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.antiviral.2012.03.011_b0200","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/rmv.589","article-title":"Clinical features and treatment of adenovirus infections","volume":"18","author":"Lenaerts","year":"2008","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0205","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1182\/blood-2010-04-259291","article-title":"How I treat adenovirus in hematopoietic stem cell transplant recipients","volume":"116","author":"Lindemans","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2012.03.011_b0210","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood-2002-07-2152","article-title":"Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease","volume":"102","author":"Lion","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2012.03.011_b0215","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/leu.2010.4","article-title":"Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation","volume":"24","author":"Lion","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.antiviral.2012.03.011_b0220","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.bmt.1703798","article-title":"Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation","volume":"31","author":"Ljungman","year":"2003","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.antiviral.2012.03.011_b0225","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1101\/gad.7.4.535","article-title":"Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis","volume":"7","author":"Lowe","year":"1993","journal-title":"Genes Dev."},{"key":"10.1016\/j.antiviral.2012.03.011_b0230","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/514978","article-title":"Disseminated adenovirus disease in immunocompromised and immunocompetent children","volume":"27","author":"Munoz","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.03.011_b0235","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jcv.2010.10.016","article-title":"Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001","volume":"50","author":"Paolino","year":"2011","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0240","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1128\/JVI.00104-08","article-title":"Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes","volume":"82","author":"Pelka","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0245","doi-asserted-by":"crossref","unstructured":"Rettig, G.R., Behlke, M.A., 2011. Progress toward in vivo use of siRNAs-II. Mol. Ther. http:\/\/dx.doi.org\/10.1038\/mt.2011.263 (Epub ahead of print).","DOI":"10.1038\/mt.2011.263"},{"key":"10.1016\/j.antiviral.2012.03.011_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.003087-0","article-title":"Adenoviruses: update on structure and function","volume":"90","author":"Russell","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0255","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(80)90568-1","article-title":"Transcripts from the adenovirus-2 major late promoter yield a single early family of 3\u2032 coterminal mRNAs and five late families","volume":"22","author":"Shaw","year":"1980","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2012.03.011_b0260","first-page":"131","article-title":"P53-independent apoptotic and necrotic cell deaths induced by adenovirus infection: suppression by E1B 19K and Bcl-2 proteins","volume":"6","author":"Subramanian","year":"1995","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.antiviral.2012.03.011_b0265","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1399-3062.2006.00184.x","article-title":"Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir","volume":"9","author":"Symeonidis","year":"2007","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.03.011_b0270","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nbt1404","article-title":"The impact of target site accessibility on the design of effective siRNAs","volume":"26","author":"Tafer","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0275","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ymthe.2006.07.007","article-title":"Silencing of HIV-1 with RNA interference: a multiple shRNA approach","volume":"14","author":"ter Brake","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2012.03.011_b0280","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1128\/JVI.70.4.2296-2306.1996","article-title":"The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells","volume":"70","author":"Tollefson","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0285","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1128\/JVI.68.7.4450-4457.1994","article-title":"The product of the adenovirus intermediate gene IVa2 is a transcriptional activator of the major late promoter","volume":"68","author":"Tribouley","year":"1994","journal-title":"J. Virol."},{"issue":"Pt. 12","key":"10.1016\/j.antiviral.2012.03.011_b0290","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1099\/0022-1317-70-12-3225","article-title":"Characterization of the adenovirus proteinase: substrate specificity","volume":"70","author":"Webster","year":"1989","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0295","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1093\/nar\/gkm437","article-title":"A systematic analysis of the effect of target RNA structure on RNA interference","volume":"35","author":"Westerhout","year":"2007","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.antiviral.2012.03.011_b0300","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1038\/sj.onc.1204861","article-title":"Regulation of the cell cycle and apoptosis by the oncogenes of adenovirus","volume":"20","author":"White","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2012.03.011_b0305","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/JVI.01725-06","article-title":"Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export","volume":"81","author":"Woo","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0310","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/01.tp.0000209195.95115.8e","article-title":"Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients","volume":"81","author":"Yusuf","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2012.03.011_b0315","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1128\/JVI.77.6.3586-3594.2003","article-title":"Requirement of the adenovirus IVa2 protein for virus assembly","volume":"77","author":"Zhang","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0320","doi-asserted-by":"crossref","first-page":"11006","DOI":"10.1128\/JVI.77.20.11006-11015.2003","article-title":"Strategic attack on host cell gene expression during adenovirus infection","volume":"77","author":"Zhao","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.03.011_b0325","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-61779-037-9_4","article-title":"Progress in RNAi-based antiviral therapeutics","volume":"721","author":"Zhou","year":"2011","journal-title":"Methods Mol. Biol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212000794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212000794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T13:27:14Z","timestamp":1593955634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354212000794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0166354212000794"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2012.03.011","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}